M Ventures — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

Artios Pharmaartios.com in 𝕏Series A · Sep 2016 · $33M

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.

BiotechHealthtechMedical Devices

Co-investorsAndera Partners Novartis Venture Fund Pfizer Venture Investments RA Capital Sofinnova Partners SV Health Investors +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.